A rocky rollout

Key Points

• The research aims to address the critical supply shortage for a new HIV prevention drug that could significantly impact the epidemic.
• Analysis of current supply levels for the HIV prevention drug
• Review of distribution channels and accessibility
• Assessment of potential impacts on HIV epidemic control
• Current supply of the HIV prevention drug is insufficient to meet demand
• Shortages could hinder efforts to reduce HIV transmission rates
• Urgent strategies are needed to enhance drug rollout and accessibility